Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026)

Caris Life Sciences' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $49000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 388.24% year-over-year to $49000.0 in Q1 2026; TTM through Mar 2026 was -$20.5 million, a 13841.5% decrease from a year earlier, with the FY2025 full-year figure at -$20.6 million, down 5791.12% from the prior year.
• Other Non Operating Income rose to $49000.0 in Q1 2026 per CAI's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $49000.0 in Q1 2026 and bottomed at -$18.3 million in Q2 2025.
• The 3-year median for Other Non Operating Income is -$57500.0 (2024), against an average of -$2.6 million.
• Across the five-year window, Other Non Operating Income tumbled 12907.8% in 2025 and jumped 388.24% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at -$26000.0 in 2024, then plunged by 8026.92% to -$2.1 million in 2025, then jumped by 102.32% to $49000.0 in 2026.
• Per Business Quant, the three latest CAI Other Non Operating Income figures stand at $49000.0 (Q1 2026), -$2.1 million (Q4 2025), and -$89000.0 (Q3 2025).